Somaxon Pharmaceutical buy phonebroker
Start price
01.09.10
/
50%
€24.00
Target price
02.09.10
€32.00
Performance (%)
0.00%
End price
02.09.10
€24.00
Summary
This prediction ended on 02.09.10 with a price of €24.00. The BUY prediction by phonebroker closed unchanged from the start price. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Somaxon Pharmaceutical | - | - | - | - |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% | 61.776% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% | 105.171% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% | 52.222% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% | 66.580% |
Comments by phonebroker for this prediction
In the thread Somaxon Pharmaceutical diskutieren
kaufen
Die Kaufempfehlung stützt sich auf folgede positive Nachricht.
Somaxon Pharmaceuticals landing Procter & Gamble as a marketing partner for the commercial launch of Somaxon's new sleeping pill Silenor.
(Stop Loss Kurs erreicht)


